Global Normothermic Perfusion of Isolated Organs Market Growth (Status and Outlook) 2024-2030

Global Normothermic Perfusion of Isolated Organs Market Growth (Status and Outlook) 2024-2030

The global Normothermic Perfusion of Isolated Organs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Normothermic Perfusion of Isolated Organs Industry Forecast” looks at past sales and reviews total world Normothermic Perfusion of Isolated Organs sales in 2022, providing a comprehensive analysis by region and market sector of projected Normothermic Perfusion of Isolated Organs sales for 2023 through 2029. With Normothermic Perfusion of Isolated Organs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Normothermic Perfusion of Isolated Organs industry.

This Insight Report provides a comprehensive analysis of the global Normothermic Perfusion of Isolated Organs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Normothermic Perfusion of Isolated Organs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Normothermic Perfusion of Isolated Organs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Normothermic Perfusion of Isolated Organs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Normothermic Perfusion of Isolated Organs.

United States market for Normothermic Perfusion of Isolated Organs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Normothermic Perfusion of Isolated Organs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Normothermic Perfusion of Isolated Organs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Normothermic Perfusion of Isolated Organs players cover TransMedics, Lung Bioengineering, OrganOx, XVIVO, TNO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Normothermic Perfusion of Isolated Organs market by product type, application, key players and key regions and countries.

Segmentation by Type:
Heart Perfusion
Liver Perfusion
Kidney Perfusion
Lung Perfusion

Segmentation by Application:
Organ Transplant Specialist Hospitals
Organ Banks
Pharmaceutical Research Organizations

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Heart Perfusion
Liver Perfusion
Kidney Perfusion
Lung Perfusion

Segmentation by Application:
Organ Transplant Specialist Hospitals
Organ Banks
Pharmaceutical Research Organizations

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
TransMedics
Lung Bioengineering
OrganOx
XVIVO
TNO
UHN
SCREEN
Bridge to Life
Organ Recovery Systems
Institut Georges Lopez
Ebers
Penn Medicine
Johns Hopkins Medicine

Please note: The report will take approximately 2 business days to prepare and deliver.